Validation of the Turkish Version of the Montreal Cognitive Assessment Scale (MoCA-TR) in patients with Parkinson's disease. (Q50659742)

17 March 2018

title

Validation of the Turkish Version of the Montreal Cognitive Assessment Scale (MoCA-TR) in patients with Parkinson's disease. (English)

1 reference

17 March 2018

1 reference

Betul Ozdilek

1

1 reference

17 March 2018

Gulay Kenangil

series ordinal

2

1 reference

17 March 2018

publication date

17 February 2014

1 reference

17 March 2018

Neuropsychology, Development and Cognition. Section D: The Clinical Neuropsychologist

published in

1 reference

17 March 2018

volume

28

1 reference

17 March 2018

issue

2

1 reference

17 March 2018

page(s)

333-343

1 reference

17 March 2018

The MoCA: well-suited screen for cognitive impairment in Parkinson disease.

cites work

1 reference

https://api.crossref.org/works/10.1080%2F13854046.2014.881554

Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13854046.2014.881554

Clinical diagnostic criteria for dementia associated with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13854046.2014.881554

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13854046.2014.881554

The Montreal cognitive assessment as a screening tool for cognitive impairment in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13854046.2014.881554

Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13854046.2014.881554

Brief screening for mild cognitive impairment in elderly outpatient clinic: validation of the Korean version of the Montreal Cognitive Assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13854046.2014.881554

Cross validation of the Montreal Cognitive Assessment in community dwelling older adults residing in the Southeastern US.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13854046.2014.881554

Predictors of deterioration in health-related quality of life in Parkinson's disease: results from the DATATOP trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13854046.2014.881554

Validity of the montreal cognitive assessment (MoCA) as a screening test for mild cognitive impairment (MCI) in a cardiovascular population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13854046.2014.881554

The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13854046.2014.881554

Montreal cognitive assessment performance in patients with Parkinson's disease with "normal" global cognition according to mini-mental state examination score

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13854046.2014.881554

A pilot study of psychometric properties of the Beijing version of Montreal Cognitive Assessment in patients with idiopathic Parkinson's disease in China.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13854046.2014.881554

Feasibility study of the Montreal Cognitive Assessment (MoCA) in patients with brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13854046.2014.881554

Motor and non-motor symptoms in Turkish patients with Parkinson's disease affecting family caregiver burden and quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13854046.2014.881554

Current concepts in mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13854046.2014.881554

Mild cognitive impairment: a clinically useful but currently ill-defined concept?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13854046.2014.881554

Reliability, validity, and optimal cutoff score of the montreal cognitive assessment (changsha version) in ischemic cerebrovascular disease patients of hunan province, china

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13854046.2014.881554

The Montreal Cognitive Assessment as a screening tool for cognitive dysfunction in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13854046.2014.881554

Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13854046.2014.881554

Limitations of the Mini-Mental State Examination in diagnosing dementia in general practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13854046.2014.881554

The validity, reliability and clinical utility of the Hong Kong Montreal Cognitive Assessment (HK-MoCA) in patients with cerebral small vessel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13854046.2014.881554

A comparison of the mini mental state exam to the Montreal cognitive assessment in identifying cognitive deficits in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13854046.2014.881554

10.1080/13854046.2014.881554

21 January 2018

Identifiers

DOI

1 reference

17 March 2018

PubMed ID

24528299

1 reference

17 March 2018